# ENCELTO

NDC: 82958-501
Generic name: revakinagene taroretcel-lwey
Labeler / Manufacturer: Neurotech Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: IMPLANT
Routes: INTRAVITREAL
Marketing started: 20250312

FDA application: BLA125798

## Active ingredients

- REVAKINAGENE TARORETCEL: 440000 [arb'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82958-501"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82958-501
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1ae9482a-b478-4e21-9166-b5fd52d3ef9c